Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan 25;5(4):494-501.
doi: 10.1002/ags3.12423. eCollection 2021 Jul.

Current state of pancreas transplantation in Japan based on the nationwide registry

Yoshito Tomimaru  1   2 , Hidetoshi Eguchi  2 , Yuichiro Doki  2 , Toshinori Ito  1   3 , Takashi Kenmochi  1   4
Affiliations
Review

Current state of pancreas transplantation in Japan based on the nationwide registry

Yoshito Tomimaru et al. Ann Gastroenterol Surg. .

Abstract

In Japan, 437 pancreas transplantations (PTx) were carried out between 2000 and 2019. Clinical data for all PTx cases are registered in the Japan Pancreas Transplant Registry of the Japan Society for Pancreas and Islet Transplantation. Here we analyzed the registry data to describe the current status of PTx in Japan. The 437 PTx included 410 from deceased donors (407 from brain-dead and 3 from non-heart-beating donors) and 27 from living donors. We investigated the clinical characteristics of the 410 PTx from deceased donors. The rate of marginal donors using expanded donor criteria was higher in Japan than in other countries. At 1/5/10 years post-PTx, the overall survival rates were 95.8%/94.2%/88.7%, and the graft survival rates were 85.9%/76.2%/67.4% for pancreas and 93.2%/90.8%/78.2% for kidney (non-censored for death). These rates were comparable to those in other countries. When stratified by PTx category, survival was significantly better following simultaneous pancreas-kidney transplantation (SPK) compared to pancreas-after-kidney transplantation (PAK) or PTx alone (PTA). Immunological rejection was more frequently the cause of graft loss in PAK/PTA cases than in SPK cases, potentially contributing to the poorer survival in PAK/PTA. These outcomes highlight two main concerns: substantial incidence of pancreas graft loss, and inferior outcomes after PAK/PTA. Overall, PTx outcome is favorable in Japan, despite the high rate of marginal donors. To improve outcomes, it is important to prevent and manage each cause of pancreas graft loss. Overcoming the poorer survival in PAK/PTA may require new immunosuppressive protocols or allogenic islet transplantation.

Keywords: marginal donor; pancreas transplantation; pancreas transplantation alone; pancreas‐after‐kidney transplantation; simultaneous pancreas‐kidney transplantation.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Authors declare no conflicts of interest for this article.

Figures

FIGURE 1
FIGURE 1
Annual numbers of pancreas transplantation (PTx) carried out in Japan between 2000 and 2019. The total of 437 PTx cases included 407 PTx from brain‐dead donors, three from non‐heart‐beating donors, and 27 from living donors
FIGURE 2
FIGURE 2
Patient and graft survival after pancreas transplantation in Japan. For graft survival analysis, death with a functioning graft was considered a graft failure
FIGURE 3
FIGURE 3
Pancreas graft survival after pancreas transplantation (PTx) according to PTx category. For pancreas graft survival analysis, death with a functioning pancreas graft was considered a pancreas graft failure. Abbreviations: PAK, pancreas‐after‐kidney transplantation; PTA, pancreas transplantation alone; SPK, simultaneous pancreas‐kidney transplantation
See this image and copyright information in PMC

References

    1. Gruessner AC, Sutherland DE, Gruessner RW. Pancreas transplantation in the United States: a review. Curr Opin Organ Transplant. 2010;15:93–101. - PubMed
    1. Kandaswamy R, Stock PG, Gustafson SK, Skeans MA, Curry MA, Prentice MA, et al. OPTN/SRTR 2018 annual data report: pancreas. Am J Transplant. 2020;20(Suppl s1):131–92. - PubMed
    1. White SA, Shaw JA, Sutherland DE. Pancreas transplantation. Lancet. 2009;373:1808–17. - PubMed
    1. Suzuki A, Kenmochi T, Maruyama M, Saigo K, Akutsu N, Iwashita C, et al. Evaluation of quality of life after simultaneous pancreas and kidney transplantation from living donors using short form 36. Transpl Proc. 2008;40:2565–7. - PubMed
    1. Smith GC, Trauer T, Kerr PG, Chadban SJ. Prospective quality‐of‐life monitoring of simultaneous pancreas and kidney transplant recipients using the 36‐item short form health survey. Am J Kidney Dis. 2010;55:698–707. - PubMed